A carregar...

Activation of natural killer cells by rituximab in granulomatosis with polyangiitis

OBJECTIVE: In the last few years, anti-CD20 antibody rituximab profoundly changed the therapeutic landscape of granulomatosis with polyangiitis (GPA). Here, we investigated whether natural killer (NK) cells may play a role in rituximab’s mechanism of action in GPA. METHODS: B cell depletion, NK cell...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Res Ther
Main Authors: Urlaub, Doris, Zhao, Shuyang, Blank, Norbert, Bergner, Raoul, Claus, Maren, Tretter, Theresa, Lorenz, Hanns-Martin, Watzl, Carsten, Merkt, Wolfgang
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6907269/
https://ncbi.nlm.nih.gov/pubmed/31829278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-019-2054-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!